SCHEMBL170856

SCHEMBL170856

CCC[C@H](C)N(C)Cc1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LIN28A Q9H9Z2 1/20 0.47
KDM4E B2RXH2 3/20 0.42
TSHR P16473 3/20 0.42
POLB P06746 1/20 0.42
KCNA5 P22460 2/20 0.41
CYP1A2 P05177 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
MAOB P27338 2/20 0.39
KCNH2 Q12809 2/20 0.38
CA2 P00918 1/20 0.38
MAOA P21397 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
SLC6A2 P23975 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL172599 0.87 TDP1 (0.50) TDP1MAPTSMN1; SMN2LIN28AKDM4E
SCHEMBL13999364 0.84 TSHR (0.50) TDP1MAPTSMN1; SMN2KDM4ETSHR
SCHEMBL23137023 0.83 TDP1 (0.46) TDP1MAPTSMN1; SMN2LIN28AKDM4E
SCHEMBL13995680 0.82 TDP1 (0.49) TDP1MAPTSMN1; SMN2LIN28AKDM4E
SCHEMBL13995302 0.82 TDP1 (0.49) TDP1MAPTSMN1; SMN2LIN28AKDM4E
SCHEMBL13995694 0.82 TDP1 (0.49) TDP1MAPTSMN1; SMN2LIN28AKDM4E
SCHEMBL12089127 0.81 TDP1 (0.55) TDP1MAPTSMN1; SMN2LIN28AKDM4E
SCHEMBL7093038 0.78 TDP1 (0.52) TDP1MAPTSMN1; SMN2LIN28AKDM4E
SCHEMBL7035519 0.75 TSHR (0.49) TDP1MAPTSMN1; SMN2LIN28ATSHR
SCHEMBL19333396 0.75 TDP1 (0.42) TDP1MAPTSMN1; SMN2LIN28AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255738-B1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO NEUROCRINE BIOSCIENCES INC (US) 2012-03-07 EP disclosed